Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical indicators of treatment-resistant psychosis
Sophie E. Legge, Charlotte Dennison, Antonio F. Pardiñas, et al.
The British Journal of Psychiatry (2019) Vol. 216, Iss. 5, pp. 259-266
Open Access | Times Cited: 78

Showing 1-25 of 78 citing articles:

Genetic architecture of schizophrenia: a review of major advancements
Sophie E. Legge, Marcos Santoro, Sathish Periyasamy, et al.
Psychological Medicine (2021) Vol. 51, Iss. 13, pp. 2168-2177
Open Access | Times Cited: 114
Dopaminergic dysfunction and excitatory/inhibitory imbalance in treatment-resistant schizophrenia and novel neuromodulatory treatment
Masataka Wada, Yoshihiro Noda, Yusuke Iwata, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 7, pp. 2950-2967
Closed Access | Times Cited: 76
Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in Schizophrenia
Antonio F. Pardiñas, Sophie Smart, Isabella R. Willcocks, et al.
JAMA Psychiatry (2022) Vol. 79, Iss. 3, pp. 260-260
Open Access | Times Cited: 71
Genomic findings in schizophrenia and their implications
Michael J. Owen, Sophie E. Legge, Elliott Rees, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 9, pp. 3638-3647
Open Access | Times Cited: 58
Translating insights from neuropsychiatric genetics and genomics for precision psychiatry
Elliott Rees, Michael J. Owen
Genome Medicine (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 74
Associations Between Schizophrenia Polygenic Liability, Symptom Dimensions, and Cognitive Ability in Schizophrenia
Sophie E. Legge, Alastair G. Cardno, Judith Allardyce, et al.
JAMA Psychiatry (2021) Vol. 78, Iss. 10, pp. 1143-1143
Open Access | Times Cited: 74
Machine learning methods to predict outcomes of pharmacological treatment in psychosis
Lorenzo Del Fabro, Elena Bondi, Francesca Serio, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 25
Psychotic disorders as a framework for precision psychiatry
Fiona Coutts, Nikolaos Koutsouleris, Philip McGuire
Nature Reviews Neurology (2023)
Closed Access | Times Cited: 25
Predictors of Treatment-Resistant and Clozapine-Resistant Schizophrenia: A 12-Year Follow-up Study of First-Episode Schizophrenia-Spectrum Disorders
Sherry Kit Wa Chan, Hei Yan Veronica Chan, William G. Honer, et al.
Schizophrenia Bulletin (2020) Vol. 47, Iss. 2, pp. 485-494
Open Access | Times Cited: 67
Genome-wide association studies in schizophrenia: Recent advances, challenges and future perspective
Charlotte Dennison, Sophie E. Legge, Antonio F. Pardiñas, et al.
Schizophrenia Research (2019) Vol. 217, pp. 4-12
Open Access | Times Cited: 66
Predicting patients who will drop out of out-patient psychotherapy using machine learning algorithms
Björn Bennemann, Brian Schwartz, Julia Giesemann, et al.
The British Journal of Psychiatry (2022) Vol. 220, Iss. 4, pp. 192-201
Open Access | Times Cited: 36
The genetic architecture of schizophrenia: review of large-scale genetic studies
Hidekazu Kato, Hiroki Kimura, Itaru Kushima, et al.
Journal of Human Genetics (2022) Vol. 68, Iss. 3, pp. 175-182
Closed Access | Times Cited: 36
Development of an individualized risk calculator of treatment resistance in patients with first-episode psychosis (TRipCal) using automated machine learning: a 12-year follow-up study with clozapine prescription as a proxy indicator
Ting Yat Wong, Hao Luo, Jennifer Tang, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Predicting treatment resistance from first-episode psychosis using routinely collected clinical information
Emanuele F. Osimo, Benjamin I. Perry, Pavan Mallikarjun, et al.
Nature Mental Health (2023) Vol. 1, Iss. 1, pp. 25-35
Open Access | Times Cited: 16
Polygenic risk scores for schizophrenia and treatment resistance: New data, systematic review and meta-analysis
Fernando Facal, Javier Costas
Schizophrenia Research (2023) Vol. 252, pp. 189-197
Closed Access | Times Cited: 13
Long-term clinical recovery and treatment resistance in first-episode psychosis: a 10-year follow-up study
Kristin Fjelnseth Wold, Isabel Kreis, Gina Åsbø, et al.
Schizophrenia (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Indicated association between polygenic risk score and treatment-resistance in a naturalistic sample of patients with schizophrenia spectrum disorders
Maren Caroline Frogner Werner, Katrine V. Wirgenes, Marit Haram, et al.
Schizophrenia Research (2020) Vol. 218, pp. 55-62
Open Access | Times Cited: 37
Neuropsychological differences between treatment-resistant and treatment-responsive schizophrenia: a meta-analysis
Edward Millgate, Olga Hide, Stephen M. Lawrie, et al.
Psychological Medicine (2021) Vol. 52, Iss. 1, pp. 1-13
Open Access | Times Cited: 32
The potential of precision psychiatry: what is in reach?
Lana Kambeitz‐Ilankovic, Nikolaos Koutsouleris, Rachel Upthegrove
The British Journal of Psychiatry (2022) Vol. 220, Iss. 4, pp. 175-178
Closed Access | Times Cited: 21
Genome-wide association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disorders
Cynthia Okhuijsen‐Pfeifer, Marte Z. van der Horst, Chad A. Bousman, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 21
Inflammatory disequilibrium and lateral ventricular enlargement in treatment-resistant schizophrenia
Wenjin Chen, Mengzhuang Gou, Leilei Wang, et al.
European Neuropsychopharmacology (2023) Vol. 72, pp. 18-29
Closed Access | Times Cited: 11
Network analysis of clinical features in patients with treatment-resistant schizophrenia
Wei Li, Jing Zhao, Na Hu, et al.
Frontiers in Psychiatry (2025) Vol. 16
Open Access
Comparison of clinical symptoms and symptom structure across different onset ages in schizophrenia inpatients
Zhaofan Liu, Xiaoying Wang, Wenjin Chen, et al.
Schizophrenia Research (2025) Vol. 277, pp. 177-184
Closed Access
Network structure of psychotic symptoms and childhood trauma in first-episode versus treatment-resistant schizophrenia
Zhaofan Liu, Xiaoying Wang, Hu Deng, et al.
Journal of Psychiatric Research (2025)
Closed Access
Recent Advances in Schizophrenia Genomics and Emerging Clinical Implications
Tim B. Bigdeli, Philip D. Harvey
Psychiatric Clinics of North America (2025)
Closed Access
Page 1 - Next Page

Scroll to top